Naloxone (Min-I-Jet) New Zealand - English - Medsafe (Medicines Safety Authority)

naloxone (min-i-jet)

pharmacy retailing (nz) ltd t/a healthcare logistics - naloxone hydrochloride dihydrate 0.4 mg/ml;   - solution for injection - 0.4 mg/ml - active: naloxone hydrochloride dihydrate 0.4 mg/ml   excipient: hydrochloric acid sodium chloride water for injection - naloxone is indicated for the complete or partial reversal of narcotic depression, including respiratory depression, induced by natural and synthetic opioids such as codeine, diamorphine, methadone, morphine and propoxyphene. it is also indicated for the diagnosis of suspected acute opioid overdosage.

SUBOXONE FILM 4/1 buprenorphine (as hydrochloride) 4 mg/naloxone (as hydrochloride dihydrate) 1 mg soluble film sachet Australia - English - Department of Health (Therapeutic Goods Administration)

suboxone film 4/1 buprenorphine (as hydrochloride) 4 mg/naloxone (as hydrochloride dihydrate) 1 mg soluble film sachet

indivior pty ltd - buprenorphine hydrochloride, quantity: 4.32 mg (equivalent: buprenorphine, qty 4 mg); naloxone hydrochloride dihydrate, quantity: 1.22 mg (equivalent: naloxone, qty 1 mg) - soluble film - excipient ingredients: acesulfame potassium; citric acid; maltitol solution; hypromellose; polyethylene oxide; sodium citrate; sunset yellow fcf; flavour; titanium dioxide; propylene glycol; purified water; industrial methylated spirit - treatment of opiate dependence within a framework of medical, social, and pyschological treatment.

Oxycodone/Naloxone Sandoz 20 mg - 10 mg tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

oxycodone/naloxone sandoz 20 mg - 10 mg tabl. prol.-rel.

sandoz sa-nv - oxycodone hydrochloride 20 mg; naloxone hydrochloride dihydrate 10,9 mg - eq. naloxone hydrochloride 10 mg - prolonged-release tablet - 20 mg - 10 mg - oxycodone hydrochloride 20 mg; naloxone hydrochloride dihydrate 10.9 mg - oxycodone, combinations

Oxycodone/Naloxone Sandoz 30 mg - 15 mg tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

oxycodone/naloxone sandoz 30 mg - 15 mg tabl. prol.-rel.

sandoz sa-nv - oxycodone hydrochloride 30 mg; naloxone hydrochloride dihydrate 16,35 mg - eq. naloxone hydrochloride 15 mg - prolonged-release tablet - 30 mg - 15 mg - oxycodone hydrochloride 30 mg; naloxone hydrochloride dihydrate 16.35 mg - oxycodone, combinations

Oxycodone/Naloxone Sandoz 5 mg - 2,5 mg tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

oxycodone/naloxone sandoz 5 mg - 2,5 mg tabl. prol.-rel.

sandoz sa-nv - naloxone hydrochloride dihydrate 2,74 mg - eq. naloxone hydrochloride 2,5 mg; oxycodone hydrochloride 5 mg - prolonged-release tablet - 5 mg - 2,5 mg - oxycodone hydrochloride 5 mg; naloxone hydrochloride dihydrate 2.74 mg - oxycodone, combinations

Oxycodone/Naloxone Sandoz 10 mg - 5 mg tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

oxycodone/naloxone sandoz 10 mg - 5 mg tabl. prol.-rel.

sandoz sa-nv - oxycodone hydrochloride 10 mg; naloxone hydrochloride dihydrate 5,45 mg - eq. naloxone hydrochloride 5 mg - prolonged-release tablet - 10 mg - 5 mg - oxycodone hydrochloride 10 mg; naloxone hydrochloride dihydrate 5.45 mg - oxycodone, combinations

Oxycodone/Naloxone Sandoz 40 mg - 20 mg tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

oxycodone/naloxone sandoz 40 mg - 20 mg tabl. prol.-rel.

sandoz sa-nv - oxycodone hydrochloride 40 mg; naloxone hydrochloride dihydrate 21,8 mg - eq. naloxone hydrochloride 20 mg - prolonged-release tablet - 40 mg - 20 mg - oxycodone hydrochloride 40 mg; naloxone hydrochloride dihydrate 21.8 mg - oxycodone, combinations

OXYCODONE HCl 10 mg/1 mL MEDSURGE oxycodone hydrochloride 10 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone hcl 10 mg/1 ml medsurge oxycodone hydrochloride 10 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium citrate dihydrate; hydrochloric acid; citric acid monohydrate; sodium chloride; sodium hydroxide; water for injections - oxycodone hcl medsurge solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE HCl 20 mg/2 mL MEDSURGE oxycodone hydrochloride 20 mg/2 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone hcl 20 mg/2 ml medsurge oxycodone hydrochloride 20 mg/2 ml solution for injection ampoule

medsurge pharma pty ltd - oxycodone hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: citric acid monohydrate; sodium chloride; water for injections; sodium hydroxide; hydrochloric acid; sodium citrate dihydrate - oxycodone hcl medsurge solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE HCl 50 mg/1 mL MEDSURGE oxycodone hydrochloride 50 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone hcl 50 mg/1 ml medsurge oxycodone hydrochloride 50 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - oxycodone hydrochloride, quantity: 50 mg/ml - injection, solution - excipient ingredients: citric acid monohydrate; sodium chloride; hydrochloric acid; sodium hydroxide; sodium citrate dihydrate; water for injections - oxycodone hcl medsurge solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.